Two of the FDA’s senior vaccine officials are leaving their positions as the agency mulls new rules and regulations over booster shots and Covid-19 vaccinations for children, according to Bloomberg and Endpoints News.
Departing the agency are Office of Vaccines Research and Review Director Marion Gruber, Ph.D. and Deputy Director Phillip Krause, M.D. Gruber plans to retire on Oct. 31, while Philips – deputy director for the FDAâs Center for Biologics Evaluation and Research, will be leaving in November.
U.S. health officials have been working to evaluate Covid vaccines and treatments at top speed, with shots from Moderna Inc., Johnson & Johnson and the partnership of Pfizer Inc. and BioNTech SE cleared in record time. Now the agency is charged with considering the administrationâs booster program, which is set to roll out additional shots for most U.S. vaccinated adults Sept. 20. -Bloomberg
